Metabolic Syndrome and DNA Damage: The Interplay of Environmental and Lifestyle Factors in the Development of Metabolic Dysfunction
Open Access
- 1 January 2015
- journal article
- Published by Scientific Research Publishing, Inc. in Open Journal of Endocrine and Metabolic Diseases
- Vol. 05 (07), 65-76
- https://doi.org/10.4236/ojemd.2015.57009
Abstract
The Metabolic Syndrome (MetS) is a complex condition which is characterized by increased risk factor for cardiovascular diseases, such as dyslipidemia, hypertension and central obesity, in addition to increased risk for type 2 diabetes mellitus (T2DM). All of these factors alone have a notable relationship with DNA damage. However, when the risks are combined, the extent for major outcomes being related to DNA damage (cancer), the consequence can be accelerated by the metabolic dysfunction. This article will illustrate the scientific evidence of the role of DNA damage in MetS, as well as discuss the interplay of major risks factors (air pollution, physical inactivity and dietary interventions) in genomic stability.Keywords
This publication has 76 references indexed in Scilit:
- Obesity depresses the anti‐inflammatory HSP70 pathway, contributing to NAFLD progressionObesity, 2014
- Short-term but not long-term hypoglycaemia enhances plasma levels and hepatic expression of HSP72 in insulin-treated rats: an effect associated with increased IL-6 levels but not with IL-10 or TNF–αMolecular and Cellular Biochemistry, 2014
- The Health Effects of Exercising in Air PollutionSports Medicine, 2013
- Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter?Cell Stress and Chaperones, 2012
- HSP70 expression: does it a novel fatigue signalling factor from immune system to the brain?Cell Biochemistry and Function, 2011
- Nut Consumption and Blood Lipid LevelsArchives of Internal Medicine, 2010
- Part A: Executive SummaryNutrition Reviews, 2009
- Aldosterone in salt-sensitive hypertension and metabolic syndromeJournal of Molecular Medicine, 2008
- LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesionsAtherosclerosis, 2007
- Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air PollutionJAMA, 2002